BR9708227A - Processo de purificação de dna duplo filamento de pureza farmacêutica preparação de dna plasmídico recombinante e composição farmacêutica - Google Patents

Processo de purificação de dna duplo filamento de pureza farmacêutica preparação de dna plasmídico recombinante e composição farmacêutica

Info

Publication number
BR9708227A
BR9708227A BR9708227A BR9708227A BR9708227A BR 9708227 A BR9708227 A BR 9708227A BR 9708227 A BR9708227 A BR 9708227A BR 9708227 A BR9708227 A BR 9708227A BR 9708227 A BR9708227 A BR 9708227A
Authority
BR
Brazil
Prior art keywords
pharmaceutical
purification process
recombinant plasmid
double strand
pharmaceutical composition
Prior art date
Application number
BR9708227A
Other languages
English (en)
Inventor
Pierre Wills
Monique Ollivier
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of BR9708227A publication Critical patent/BR9708227A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9708227A 1996-03-21 1997-03-17 Processo de purificação de dna duplo filamento de pureza farmacêutica preparação de dna plasmídico recombinante e composição farmacêutica BR9708227A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9603519A FR2746412B1 (fr) 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique
PCT/FR1997/000472 WO1997035002A1 (fr) 1996-03-21 1997-03-17 Purification d'adn plasmidique de qualite pharmaceutique

Publications (1)

Publication Number Publication Date
BR9708227A true BR9708227A (pt) 1999-07-27

Family

ID=9490391

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708227A BR9708227A (pt) 1996-03-21 1997-03-17 Processo de purificação de dna duplo filamento de pureza farmacêutica preparação de dna plasmídico recombinante e composição farmacêutica

Country Status (15)

Country Link
US (1) US6730781B1 (pt)
EP (1) EP0902835A1 (pt)
JP (1) JP2000506736A (pt)
KR (1) KR100502116B1 (pt)
AU (1) AU730755B2 (pt)
BR (1) BR9708227A (pt)
CA (1) CA2249465A1 (pt)
CZ (1) CZ295587B6 (pt)
FR (1) FR2746412B1 (pt)
HU (1) HU225426B1 (pt)
IL (1) IL126268A0 (pt)
NO (1) NO984342L (pt)
SK (1) SK129198A3 (pt)
WO (1) WO1997035002A1 (pt)
ZA (1) ZA972462B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
MXPA02011463A (es) * 2000-05-26 2004-09-06 Centelion Purificacion de una formacion de triple helice con un oligonucleotido inmovilizado.
FR2822476B1 (fr) * 2001-03-23 2004-04-02 Aventis Pharma Sa Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice
KR101002499B1 (ko) * 2001-03-23 2010-12-17 센텔리옹 에스아에스 2본쇄 dna 표적 서열을 3중 나선 상호작용에 의해 정제 및 검출하는 방법
AU2003267175A1 (en) 2002-09-13 2004-04-30 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
EP1628749B1 (en) 2003-05-30 2019-07-31 VGXI, Inc. Devices and methods for biomaterial production
MXPA06003004A (es) * 2003-09-17 2006-06-23 Centelion Metodo de preparacion de acido desoxirribonucleico plasmidico de grado farmaceutico.
CA2559368A1 (en) * 2004-04-19 2005-10-27 Centelion Method for purifying plasmid dna
EP2246413A3 (en) * 2004-04-19 2011-10-26 Centelion Method for purifying plasmid DNA having pharmaceutical quality
BRPI0515418A (pt) 2004-08-16 2008-07-22 Nature Technology Corp método para a produção de dna de plasmìdio super-enrolado fechado covalentemente e composição de matéria
ES2529675T3 (es) 2004-11-30 2015-02-24 Merial Ltd. Dispositivos de mezclado para la lisis química de células
US20120258502A1 (en) * 2011-04-08 2012-10-11 Vinod Pandiripally Method of producing recombinant plasmid dna using substantially solid growth medium
US20120283503A1 (en) * 2011-04-29 2012-11-08 The Johns Hopkins University Nanoparticle loaded stem cells and their use in mri guided hyperthermia
CN116790578B (zh) * 2023-08-22 2023-12-12 赛奥斯博生物科技(北京)有限公司 一种基于碱裂解法快速纯化质粒的生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3888079T2 (de) * 1987-10-22 1994-07-14 Asahi Optical Co Ltd Poröses keramisches Material.
JPH01135792A (ja) * 1987-11-20 1989-05-29 Mitsui Toatsu Chem Inc 核酸の分離・精製方法
CA2006008C (en) * 1988-12-20 2000-02-15 Donald J. Kessler Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
AU6125294A (en) * 1993-01-13 1994-08-15 Genetics Institute Inc. Process for producing m-csf 223
US5503816A (en) * 1993-09-27 1996-04-02 Becton Dickinson And Company Silicate compounds for DNA purification
CA2182388C (en) * 1994-02-07 2007-08-07 Metin Colpan Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
US5576196A (en) * 1995-01-13 1996-11-19 Vical Incorporated Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
US6750333B1 (en) 1996-02-06 2004-06-15 Roche Diagnostics Gmbh Process for preparing purified nucleic acid and the use thereof

Also Published As

Publication number Publication date
AU2166197A (en) 1997-10-10
EP0902835A1 (fr) 1999-03-24
NO984342D0 (no) 1998-09-18
CZ295587B6 (cs) 2005-08-17
JP2000506736A (ja) 2000-06-06
HUP9902152A3 (en) 2001-04-28
HU225426B1 (en) 2006-11-28
HUP9902152A2 (hu) 1999-11-29
CA2249465A1 (fr) 1997-09-25
KR20000064693A (ko) 2000-11-06
FR2746412B1 (fr) 1998-06-12
SK129198A3 (en) 1999-03-12
IL126268A0 (en) 1999-05-09
AU730755B2 (en) 2001-03-15
US6730781B1 (en) 2004-05-04
FR2746412A1 (fr) 1997-09-26
KR100502116B1 (ko) 2005-12-20
ZA972462B (en) 1997-09-29
NO984342L (no) 1998-09-18
CZ298498A3 (cs) 1999-01-13
WO1997035002A1 (fr) 1997-09-25

Similar Documents

Publication Publication Date Title
BR9708227A (pt) Processo de purificação de dna duplo filamento de pureza farmacêutica preparação de dna plasmídico recombinante e composição farmacêutica
DE69530183D1 (de) Herstellung von plasmid dns von pharmazeutischer güte
ZA987428B (en) Succinic acid production and purification
AU4803196A (en) Recombinant DNA virus and method for preparation thereof
NZ328261A (en) 4-aryl substituted fused cycloalkanopyridines and pharmaceutical compositions containing them, intermediates
BR9506883A (pt) Gene dna recombinante bactéria corineforme processos para produzir l-lizina e para produzir ácido l-glutâmico
ZA9810650B (en) Process to stabilize proteins
IT1291366B1 (it) Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
IL113484A0 (en) Viral proteins pharmaceutical compositions containing them their preparation and use
FI972030A0 (fi) Puhdistettuja papillomavirusproteiineja
AU7489300A (en) Purification and recovery of dicarboxylic acids using melt crystallization
BR9606270A (pt) Processo para a produção da proteína do interferon beta-cis humano recombinante e proteína de interferon beta-cis humano recombinante
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
AU3057399A (en) Glass microfiber column and method for the preparation and purification of plasmid dna using the same
HUP9900317A3 (en) Pharmaceutical composition useful for nucleic acid transfection, and use thereof
EP1186615A4 (en) PROTEIN AND DNA OF THIS PROTEIN
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
IL122412A0 (en) Recombinant viral nucleic acids
HUP9904173A3 (en) Pharmaceutical composition for treating viral diseases
AU7173698A (en) Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
EP1220896A4 (en) NEW HUMANE LIPASE PROTEINS, FOR CODING NUCLEIC ACIDS AND THEIR USE
EE03934B1 (et) Enantiomeerselt rikastatud N-derivaaditud laktaamide valmistamismeetod
AU2001273287A1 (en) Large scale expression and purification of recombinant proteins
AU5542101A (en) Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]